Jon Cooper
Jon Cooper
Verified email at
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mitochondrial complex I deficiency in Parkinson's disease
AHV Schapira, JM Cooper, D Dexter, JB Clark, P Jenner, CD Marsden
Journal of neurochemistry 54 (3), 823-827, 1990
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
R Wilson, R Ainscough, K Anderson, C Baynes, M Berks, J Bonfield, ...
Nature 368 (6466), 32-38, 1994
Mitochondrial complex I defi ciency in Parkinson’s disease
AHV Schapira, JM Cooper, D Dexter, P Jenner, JB Clark, CD Marsden
LANCET 1, 1269-1269, 1989
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases
MWJ Cleeter, JM Cooper, VM Darley-Usmar, S Moncada, AHV Schapira
FEBS letters 345 (1), 50-54, 1994
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
ME Gegg, JM Cooper, KY Chau, M Rojo, AHV Schapira, JW Taanman
Human molecular genetics 19 (24), 4861-4870, 2010
Mitochondrial defect in Huntington's disease caudate nucleus
M Gu, MT Gash, VM Mann, F Javoy‐Agid, JM Cooper, AHV Schapira
Annals of Neurology: Official Journal of the American Neurological …, 1996
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
AHV Schapira, VM Mann, JM Cooper, D Dexter, SE Daniel, P Jenner, ...
Journal of neurochemistry 55 (6), 2142-2145, 1990
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ...
Neurobiology of disease 42 (3), 360-367, 2011
A review of the immobilization of enzymes in electropolymerized films
PN Bartlett, JM Cooper
Journal of Electroanalytical Chemistry 362 (1-2), 1-12, 1993
Chaperone-mediated autophagy markers in Parkinson disease brains
L Alvarez-Erviti, MC Rodriguez-Oroz, JM Cooper, C Caballero, I Ferrer, ...
Archives of neurology 67 (12), 1464-1472, 2010
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
P Ashton, RA Patchell, J Cooper, BA Young
US Patent 5,836,935, 1998
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
ME Gegg, D Burke, SJR Heales, JM Cooper, J Hardy, NW Wood, ...
Annals of neurology 72 (3), 455-463, 2012
A novel α-synuclein missense mutation in Parkinson disease
C Proukakis, CG Dudzik, T Brier, DS MacKay, JM Cooper, GL Millhauser, ...
Neurology 80 (11), 1062-1064, 2013
Biochemical abnormalities and excitotoxicity in Huntington's disease brain
SJ Tabrizi, MWJ Cleeter, J Xuereb, JW Taanman, JM Cooper, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
Chaste: an open source C++ library for computational physiology and biology
GR Mirams, CJ Arthurs, MO Bernabeu, R Bordas, J Cooper, A Corrias, ...
PLoS computational biology 9 (3), e1002970, 2013
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
JM Cooper, PBO Wiklander, JZ Nordin, R Al‐Shawi, MJ Wood, M Vithlani, ...
Movement Disorders 29 (12), 1476-1485, 2014
Irreversible inhibition of mitochondrial complex I by 1‐methyl‐4‐phenylpyridinium: evidence for free radical involvement
MWJ Cleeter, JM Cooper, AHV Schapira
Journal of neurochemistry 58 (2), 786-789, 1992
Biosensors: a practical approach
AEG Cass
(No Title), 1990
The system can't perform the operation now. Try again later.
Articles 1–20